Dad On Retire
  • About us
  • Contacts
  • Email Whitelisting
  • Home
  • Privacy Policy
  • Terms and Conditions
  • Thank you
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Dad On Retire
No Result
View All Result
Home News

‘Sweetheart’ drug deals with China are a clear and present danger to America: Sen. Hawley

DadOnRetire by DadOnRetire
April 3, 2023
in News
0
‘Sweetheart’ drug deals with China are a clear and present danger to America: Sen. Hawley
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Critical drug shortages in the U.S. are on the rise due to a deal that gave China dominance over the global supply chain, posing a national security threat, Sen. Josh Hawley told Fox News.

Drug shortages in the U.S. increased 30% in 2022 compared to the year prior, according to a Senate Homeland Security & Governmental Affairs report released last month. Some antibiotics, anesthetics, cancer treatments, emergency room supplies and kids’ medicines are among the drugs facing shortages. 

‘We are dependent on China overwhelmingly for our critical medical supply chains,’ Hawley, who sits on the committee, said. ‘You talk about being dependent, you talk about a national security threat, that’s a national security threat.’

‘That is a direct threat to our independence and to the health of our people,’ he said.

CHINA CONTROLLING THE GLOBAL DRUG SUPPLY CHAIN THREATENS U.S. NATIONAL SECURITY: HAWLEY

In some cases, 90% of the key ingredients originate in China or India, according to the Senate report. It also found that active drug shortages peaked in the U.S. at the end of 2022. 

‘We are dependent on China overwhelmingly for our critical medical supply chains,’ Hawley said. ‘You look at the precursors, the key precursors for making pharmaceutical drugs, prescriptions that Americans rely on, 60% of those are made in China or India.’

‘We should make these drugs, including the precursors in the United States of America,’ the Missouri Republican told Fox News. ‘We can start by withdrawing China’s most favored nation status, the sweetheart trade deal that we gave them 20 years ago.’

The U.S. Senate granted China most favored nation status ahead of Beijing joining the World Trade Organization. In practice, the U.S. is obligated to provide China with preferential treatment for trade deals and tariffs. 

Hawley recently proposed a bill that would rescind China’s most favored nation trade status. The legislation would also ‘subject imports from China to higher tariff rates,’ according to his office.

‘During COVID, China threatened to withhold a key precursor drug, a key precursor element for cancer treatments,’ Sen. Hawley told Fox News. ‘If they had gone through and done that, it would have cut our supply in half at all of our [Department of Veterans Affairs] hospitals across the country overnight.’ 

Additionally, the number of FDA-approved pharmaceutical ingredient manufacturers based in China more than doubled between 2010 – 2015, according to the Senate report. 

Bringing domestic drug manufacturing back to the states is also gaining bipartisan momentum in the House of Representatives.

Two Republicans and two Democrats last month launched the Domestic Pharmaceutical Manufacturing Caucus, which is intended ‘to reduce American reliance on foreign adversaries, head off potential supply chain disruptions, and ensure a steady supply of pharmaceuticals in the event of public health emergencies or natural disasters,’ according to a press release. 

‘Currently, only about 10% of our critical prescription drugs or their precursors are made in America, 90% made somewhere else,’ Hawley told Fox News. ‘Listen, not only is that bad for patients, it’s bad for workers.’

Bringing high-paying pharmaceutical jobs back to the U.S. would help the economy while simultaneously cutting reliance on Chinese manufacturing, the senator said. But building domestic drug manufacturing facilities could take years, which, in the case of any future world conflicts, could pose a threat.

‘If we don’t do anything now, ahead of the curve, we will be at their mercy,’ he told Fox News. ‘We need to bring good-paying jobs back to this country, making these critical supplies that we literally rely on to live.’

To watch the full interview with Hawley, click here.

Jon Michael Raasch is an associate producer/writer with Fox News Digital Originals.

This post appeared first on FOX NEWS

Critical drug shortages in the U.S. are on the rise due to a deal that gave China dominance over the global supply chain, posing a national security threat, Sen. Josh Hawley told Fox News.

Drug shortages in the U.S. increased 30% in 2022 compared to the year prior, according to a Senate Homeland Security & Governmental Affairs report released last month. Some antibiotics, anesthetics, cancer treatments, emergency room supplies and kids’ medicines are among the drugs facing shortages. 

‘We are dependent on China overwhelmingly for our critical medical supply chains,’ Hawley, who sits on the committee, said. ‘You talk about being dependent, you talk about a national security threat, that’s a national security threat.’

‘That is a direct threat to our independence and to the health of our people,’ he said.

CHINA CONTROLLING THE GLOBAL DRUG SUPPLY CHAIN THREATENS U.S. NATIONAL SECURITY: HAWLEY

In some cases, 90% of the key ingredients originate in China or India, according to the Senate report. It also found that active drug shortages peaked in the U.S. at the end of 2022. 

‘We are dependent on China overwhelmingly for our critical medical supply chains,’ Hawley said. ‘You look at the precursors, the key precursors for making pharmaceutical drugs, prescriptions that Americans rely on, 60% of those are made in China or India.’

‘We should make these drugs, including the precursors in the United States of America,’ the Missouri Republican told Fox News. ‘We can start by withdrawing China’s most favored nation status, the sweetheart trade deal that we gave them 20 years ago.’

The U.S. Senate granted China most favored nation status ahead of Beijing joining the World Trade Organization. In practice, the U.S. is obligated to provide China with preferential treatment for trade deals and tariffs. 

Hawley recently proposed a bill that would rescind China’s most favored nation trade status. The legislation would also ‘subject imports from China to higher tariff rates,’ according to his office.

‘During COVID, China threatened to withhold a key precursor drug, a key precursor element for cancer treatments,’ Sen. Hawley told Fox News. ‘If they had gone through and done that, it would have cut our supply in half at all of our [Department of Veterans Affairs] hospitals across the country overnight.’ 

Additionally, the number of FDA-approved pharmaceutical ingredient manufacturers based in China more than doubled between 2010 – 2015, according to the Senate report. 

Bringing domestic drug manufacturing back to the states is also gaining bipartisan momentum in the House of Representatives.

Two Republicans and two Democrats last month launched the Domestic Pharmaceutical Manufacturing Caucus, which is intended ‘to reduce American reliance on foreign adversaries, head off potential supply chain disruptions, and ensure a steady supply of pharmaceuticals in the event of public health emergencies or natural disasters,’ according to a press release. 

‘Currently, only about 10% of our critical prescription drugs or their precursors are made in America, 90% made somewhere else,’ Hawley told Fox News. ‘Listen, not only is that bad for patients, it’s bad for workers.’

Bringing high-paying pharmaceutical jobs back to the U.S. would help the economy while simultaneously cutting reliance on Chinese manufacturing, the senator said. But building domestic drug manufacturing facilities could take years, which, in the case of any future world conflicts, could pose a threat.

‘If we don’t do anything now, ahead of the curve, we will be at their mercy,’ he told Fox News. ‘We need to bring good-paying jobs back to this country, making these critical supplies that we literally rely on to live.’

To watch the full interview with Hawley, click here.

Jon Michael Raasch is an associate producer/writer with Fox News Digital Originals.

This post appeared first on FOX NEWS
Previous Post

Defiant Trump announces Florida event just hours after Tuesday’s court appearance in New York

Next Post

WI’s Protasiewicz, Kelly face off in most expensive Supreme Court race in US history

DadOnRetire

DadOnRetire

Next Post
WI’s Protasiewicz, Kelly face off in most expensive Supreme Court race in US history

WI's Protasiewicz, Kelly face off in most expensive Supreme Court race in US history

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
AG threatens to sue nonprofit accused of going woke if taxpayer money isn’t returned: ‘Choice is yours’

AG threatens to sue nonprofit accused of going woke if taxpayer money isn’t returned: ‘Choice is yours’

February 10, 2023
Arkansas Democrat defends Gov. Sarah Huckabee Sanders amid attack from California’s Gavin Newsom

Arkansas Democrat defends Gov. Sarah Huckabee Sanders amid attack from California’s Gavin Newsom

February 9, 2023
Trump gears up for 2024 rally in Waco, Texas amid ongoing federal investigation, possible NY indictment

Trump gears up for 2024 rally in Waco, Texas amid ongoing federal investigation, possible NY indictment

March 19, 2023

Here’s why every American should be talking about politics and religion on Thanksgiving

November 23, 2023
US military bases that housed Afghan evacuees suffered $260 million in damage

US military bases that housed Afghan evacuees suffered $260 million in damage

0
George Santos scandal brings renewed attention to Biden’s fabrications

George Santos scandal brings renewed attention to Biden’s fabrications

0
Texas ranch owner near border catches men attempting to break into house

Texas ranch owner near border catches men attempting to break into house

0
Maryland Rep. Jamie Raskin diagnosed with ‘serious but curable’ cancer

Maryland Rep. Jamie Raskin diagnosed with ‘serious but curable’ cancer

0
‘Not constitutional’: Congress invokes new War Powers Resolution to reject Trump’s strikes on Iran

‘Not constitutional’: Congress invokes new War Powers Resolution to reject Trump’s strikes on Iran

June 22, 2025
At UN Security Council, Israel’s ambassador slams Iranian hypocrisy

At UN Security Council, Israel’s ambassador slams Iranian hypocrisy

June 22, 2025
Watch: Bernie Sanders reacts to Trump’s Iran strikes in real time at ‘Fighting Oligarchy’ rally

Watch: Bernie Sanders reacts to Trump’s Iran strikes in real time at ‘Fighting Oligarchy’ rally

June 22, 2025
Expert confident Iran’s nuclear program is ‘no longer’ after massive US strike

Expert confident Iran’s nuclear program is ‘no longer’ after massive US strike

June 22, 2025

Recent News

‘Not constitutional’: Congress invokes new War Powers Resolution to reject Trump’s strikes on Iran

‘Not constitutional’: Congress invokes new War Powers Resolution to reject Trump’s strikes on Iran

June 22, 2025
At UN Security Council, Israel’s ambassador slams Iranian hypocrisy

At UN Security Council, Israel’s ambassador slams Iranian hypocrisy

June 22, 2025
Watch: Bernie Sanders reacts to Trump’s Iran strikes in real time at ‘Fighting Oligarchy’ rally

Watch: Bernie Sanders reacts to Trump’s Iran strikes in real time at ‘Fighting Oligarchy’ rally

June 22, 2025
Expert confident Iran’s nuclear program is ‘no longer’ after massive US strike

Expert confident Iran’s nuclear program is ‘no longer’ after massive US strike

June 22, 2025

Disclaimer: DadOnRetire.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2025 dadonretire.com | All Rights Reserved

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 dadonretire.com | All Rights Reserved